Kylo Peptides
kylopeptides.com
Email me when this record changes
Following this record emails you when it gains a dated entry or its published claims are re-read, and nothing about any other supplier. No topic below is ticked: tick one only if you also want it in the same email.
Compiled automatically from the dated observations in this vendor's record. How we evaluate.
Never merged into one number. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.
Kylo Peptides' own COA library links two of its oldest certificate rows, a plain Retatrutide entry and a BPC-157 entry, to scanned images whose printed accession numbers and purity figures do not match what the table itself prints; the accession range the table cites for that date window is the identical run of Blank Peptides-client placeholder documents, at matching purity figures, that koipeptidescanada.com also publishes as its own. The About page states that three labs test every vial while naming two outside labs, Janoshik Labs and Freedom Diagnostics, plus in-house testing; the Contact page instead claims four independent laboratories while naming only three, with no fourth identified. Kylo Labs LLC's registered Sheridan, Wyoming address is identical down to the suite letter to the one koipeptides.com's structured data lists for Koi Research Labs LLC, while the current retatrutide lot's certificate matches its own table row and the lab's lookup returns the same six accession codes the current table prints. Has anyone who bought from both Kylo Peptides and Koi Peptides Canada compared certificates and found the same batch documents under both names?
What the record holds
SAME DAY, CUTOFF STATED
“Same-day dispatch before 2 PM PT from one of two warehouses, Austin, TX or Long Beach, CA”
Cutoff 2 PM PT, warehouse chosen by region. The sitewide banner advertises free US shipping over $150 while the shipping-policy body waives the flat $19.99 USPS Priority rate only once an order clears $200, the fifty-dollar gap the record carries. Cold-chain orders dispatch Monday or Tuesday only; international only to qualifying institutions with pre-approval. Policy carries a July 2026 revision dateline.
Read from this supplier's own pages on 2026-08-26. This publication has never placed an order with any supplier. This row records what is written and measures nothing about what actually happens after an order.
$89.95
Compound retatrutide 10mg
Listed as Retatrutide (GLP-3), 10mg size button (default selected), product slug glp-3-rt, variation_id 36
Price as recorded $89.95, marked down from a $99.95 regular price, per the WooCommerce Store API and the product page's own data-price button attribute on this date. The 20mg, 30mg, and 60mg buttons on the same page price at $169.95, $229.95, and $459.95 (60mg marked out of stock).
Read on 2026-08-26. One reading on one day, and prices are not tracked over time here.
This supplier was not part of the Trustpilot reading of 2026-08-25, which covered 59 of the 126 suppliers on file. That is a fact about this publication's coverage, stated rather than left to be read either way.
4 claims from this publication's own dossier on this supplier were read again against the live site on 2026-08-26: 1 held, 3 corrected before publication.
A corrected claim is an error of ours that the re-read caught before it reached a page. This line tracks this publication's own accuracy. It says nothing about the supplier.
Dated entries
4 observations on file, recorded 2026-08-26. Newest first, appended and never rewritten.
The COA library at /coa/, fetched today, lists 26 lot rows in a table format, the six plus five plus fifteen enumerated below. Six are dated August 22 2026 and issued by Freedom Diagnostics: Retatrutide 10mg, accession 2608170152, lot SD-260728-1, purity 99.87 percent by HPLC-UV with LC-MS identity; BPC-157 10mg accession 2608170153, purity 99.80 percent; GHK-Cu 50mg accession 2608170154, purity 99.94 percent; KLOW 80mg accession 2608170155, purity 99.84 percent; CJC/IPA no DAC 10mg accession 2608170156, purity 99.62 percent; GLOW 70mg accession 2608170157, purity 99.67 percent. Five are dated August 20 2026 and issued by Vanguard Laboratory: a GLP-3 (retatrutide) row, laboratory ID V260814-13 001, lot White Cap, purity greater than 99.80 percent by HPLC-UV/VIS; BPC-157 lot Clear Cap 002 and GHK-Cu lot Blue Cap 003, each also greater than 99.80 percent by the same HPLC-UV/VIS method; GLOW lot Purple Cap 006 at greater than 99.50 percent, plus or minus 0.18, by that method, the figure both the live table row and the certificate document itself print; CJC-1295 plus Ipamorelin lot Black Cap 004 at 98.56 percent. A longer tail of older Freedom Diagnostics rows runs from December 2025 through June 2026, covering BPC-157, TB-500, GHK-Cu, KLOW Blend, GLOW Blend, Tesamorelin, SS-31, KPV, Kisspeptin-10, Selank, Semax, NAD+, CJC-1295 plus Ipamorelin, a plain Retatrutide row at accession 2606170094 (purity 99.760 percent, reported June 20 2026), and Bacteriostatic Water. I downloaded the current retatrutide certificate directly (filed as KYLO2608170152.pdf): a text-layer document naming the client as KYLO Research Labs LLC, accession 2608170152, received 8/17/2026, reported 8/22/2026, lot SD-260728-1, product Retatrutide 10mg, purity 99.87 percent by HPLC with UV detection coupled to mass spectrometry, identity reading GLP RT, net content 11.28 mg against the 10mg label, signed by a chemist named Alex Johnson, the same signature line that appears on Freedom Diagnostics documents I have opened for other vendors using this lab. This document matches the table row that links to it. I also downloaded the Vanguard document behind the first Vanguard row: Vanguard Laboratory, 2635 Parkmont Ln, Olympia WA 98502, compound GLP-3, quantity 10 mg, laboratory ID V260814-13 001, lot White Cap, dated 8/20/2026, identity by HPLC-UV/VIS reading a match against the reference standard, chromatographic purity by HPLC-UV/VIS of 99.80 percent plus or minus 0.18 percent, quantity by HPLC-UV/VIS of 10.06 mg, reported by a named laboratory director and approved by a named operations manager, citing A2LA Certificate #6377.01.01 on its face. Two of the older table rows do not match their own linked files. The plain Retatrutide row (table: accession 2606170094, purity 99.760 percent) links to a file named Retatrutide-10mg.pdf, which is a single full-page scanned image rather than a text document; extracted and read, it shows client KYLO peptides, accession 2605290206, received 05/29/2026, reported 05/31/2026, lot Clear Cap/Bronze Crimp, product Retatrutide 10mg, purity 99.97 percent, net content 33.21 mg, none of which matches the accession number or purity the table itself prints for that row. The BPC-157 row (table: accession 2604060200, purity 99.283 percent) shows the same pattern: its linked file is also a scanned image, showing client KYLO peptides, accession 2605290215, received 05/29/2026, reported 05/31/2026, lot Clear Blue Cap, purity 99.62 percent, net content 12.14 mg, again a different document from the one the table describes.
On lab verifiability. Freedom Diagnostics Testing's own homepage, fetched today, carries the same facts recorded elsewhere for this lab: a Franklin, Tennessee address, an establishment year of 2023, a two to four day turnaround claim, roughly 42,000 published certificates, and no accreditation language anywhere on the page; the words accreditation, ISO 17025, A2LA, and CLIA do not appear. Kylo's own quality-standards page names this lab directly, unlike Koi Peptides Canada's equivalent page, which never names its lab at all, stating that methods run at FreedomDiagnostics and that independence is structural rather than a marketing line, and separately stating that methods are verified per USP <1225>/<1226> and ISO/IEC 17025:2017. The About page and the Contact page go further and call Freedom Diagnostics an independent ISO/IEC 17025-accredited laboratory outright, a claim the lab's own site does not make for itself today. Querying the lab's public accession lookup directly for Kylo, Kylo Labs, and Kylo Research Labs each returned the identical six codes, KYLO2608170152 through KYLO2608170157, matching the current COA table exactly. The same lookup returns nothing for Kylo peptides as a search string, even though the client field on the two scanned May 2026 documents described above, the ones actually linked from the retatrutide and BPC-157 rows, reads KYLO peptides; their search-code prefix on the document face is Pept, not Kylo, so those two documents sit outside every Kylo-prefixed lookup, and I did not establish what company name the lab has on file under that prefix. A cross-vendor overlap worth recording here: the same lab's public index, queried separately for Blank Peptides while researching koipeptidescanada.com, returned the identical accession run 2604060200 through 2604060227 that the older half of Kylo's own COA table cites by number, BPC-157 at 2604060200 and KLOW Blend at 2604060227 among them, all dated to an April 6 2026 receipt. Direct extraction confirms accession 2604060200 reads client Blank Peptides, lot BPC-157 10mg 665394, purity 99.283 percent, the same purity figure Kylo's own table prints for its BPC-157 row. So the generic, non-vendor-specific batch of paperwork that koipeptidescanada.com publishes as its own is the same accession run, with the same purity figures, that kylopeptides.com's own COA table cites for the same calendar window, even though the files Kylo actually links to for those two rows turn out to be the separate KYLO peptides scanned images rather than the Blank Peptides originals.
Benchmark and prices read on 2026-08-26 from the product page and the WooCommerce Store API. Retatrutide (GLP-3), single vial, not a kit, across four size buttons: 10mg selected by default at $89.95, marked down from a $99.95 regular price per the Store API's own regular-price and on-sale fields, re-pulled directly during verification; the rendered page's size buttons carry the sale figure alone with no struck-through regular price, and the only $99.95 amounts visible on the page belong to the Tirzepatide and AOD-9604 tiles in the related-products strip, so the markdown is a data-layer fact rather than a displayed one; 20mg at $169.95; 30mg at $229.95; 60mg at $459.95 and marked out of stock. The aggregate offer schema on the page separately confirms a low price of $89.95 and a high price of $459.95 in USD. CAS 2381089-83-2, molecular weight 4731.33 g/mol, 39 amino acids, formula C221H342N46O68. Storage per the product specification block: lyophilized at minus 20 degrees C, reconstituted at 2 to 8 degrees C short term. Shipping: the sitewide banner and most page copy advertise free US shipping over $150, but the shipping-policy page's own body text states the flat $19.99 USPS Priority rate is waived only once an order clears $200, a fifty-dollar gap between the threshold advertised sitewide and the one written into the policy body on the same page. Same-day dispatch before 2 PM PT from one of two warehouses, Austin, TX or Long Beach, CA, chosen by region; international shipping to qualifying institutions in Canada, the UK, the EU, Australia, and select APAC countries, gated on an institutional address, an end-use declaration for restricted compounds, and pre-approval; cold-chain orders dispatch Monday or Tuesday only. The shipping policy and the Terms of Service both carry a July 2026 revision date on their face. Payment methods differ across three pages: the FAQ states credit card, debit card, or Apple Pay; the Terms of Service instead lists major credit card, ACH, and wire transfer, plus net-30 terms for verified institutions; the refund policy separately acknowledges cryptocurrency payment, stating that crypto payments are refunded in the same cryptocurrency rather than in fiat. Checkout itself was not reached, so what is actually offered there is unverified. Entity: Kylo Labs LLC, 30 N Gould St, Ste R, Sheridan, WY 82801, phone +1 350 252 3314, governing law Wyoming with disputes seated in Sheridan County, consistent across the Contact page and the Terms of Service, unlike the two-name conflict recorded for koipeptidescanada.com.
CAUTIONCautions noted, including the wider Koi and Kylo family relationship this assignment asked to be documented explicitly. First, a lab-count inconsistency: the About page headline states that three labs test every vial, and its body names two outside labs, Janoshik Labs and Freedom Diagnostics, alongside in-house testing, which totals three; the Contact page instead states four independent laboratories while naming only three, Janoshik Analytical, Freedom Diagnostics, and Vanguard Laboratory, with no fourth identified anywhere I found. Second, on the Janoshik accreditation claim specifically: the Contact page calls Janoshik ISO/IEC 17025 accredited, but I could not reach janoshik.com today to check that against the lab's own site; a non-browser fetch of its plain homepage failed a TLS handshake through curl and returned HTTP 403 through a Python fetch carrying the same identifying user agent, and a same-session fetch of vanguardlaboratory.com returned the same 403 pattern. Both should be treated as unverified today rather than confirmed in either direction. Third, the template-reuse finding detailed in the lab-verifiability note above: two of the oldest linked certificates in Kylo's own COA library are scanned images whose printed accession numbers and purity figures do not match what the table itself prints for those rows, and the accession range the table cites for that date window is the identical run of Blank Peptides-client placeholder documents also published, under matching figures, on koipeptidescanada.com's live COA page. Fourth, on the family relationship itself: kylopeptides.com's About page, its five-tenet framework, and its What We Don't Do list are structured almost identically to koipeptidescanada.com's About page, matched bullet for bullet in places, despite different stated founding years (Kylo: 2021; Koi: 2022) and different origin stories (Kylo: former contract-manufacturer process chemists; Koi: a five-vendor BPC-157 test that failed three of five). Kylo's quality-standards page and Koi's quality-standards and methodology pages all carry an identical named-reviewer byline, a doctoral-credentialed name not reprinted here per the fabrication-gate rule, with adjacent mid-May 2026 review dates. Separately and more concretely, koipeptides.com's own structured data names its legal entity Koi Research Labs LLC at street address 30 N Gould St Ste R, Sheridan, WY 82801, the identical address, suite letter included, that Kylo Labs LLC prints as its own registered office on every kylopeptides.com page I loaded; koipeptidescanada.com names koipeptides.com as its own United States edition in reciprocal hreflang alternate tags and hot-links its entry-gate logo image from koipeptides.com's uploads directory, though every clickable logo anchor on the Canadian site points only to itself. I could not determine today whether that Sheridan, Wyoming address is a shared operating facility or a shared commercial registered-agent address, a well-known Wyoming registered-agent building used by many unrelated LLCs, so the address match is reported as confirmed and its operational meaning as open. Fifth, and a correction to this assignment's working hypothesis, flagged for Fable: koiaminos.com, fetched today, is not evidence of a koipeptidescanada.com sibling relationship. It is a separate WordPress and React buyer's-guide site, titled as a ranking of the best Retatrutide suppliers of 2026, that names kylopeptides.com its top pick with a claimed 96 out of 100 score, describes it using language that closely tracks kylopeptides.com's own marketing (an ISO/IEC 17025 accredited external laboratory, a public lot-searchable COA library, the same 10 to 60mg size range), and links to kylopeptides.com's actual retatrutide product page carrying utm_source=koiaminos and utm_medium=referral tracking parameters; kylopeptides.com in turn runs a working, generic WordPress affiliate-program page at /affiliate-home/. No page on koiaminos.com names koipeptidescanada.com, Koi Peptides, or Koi Research Labs anywhere I found. The evidenced chain runs koipeptidescanada.com to koipeptides.com to kylopeptides.com by way of the shared Sheridan address, with koiaminos.com sitting outside that chain as an apparent referral partner to kylopeptides.com specifically rather than a common-ownership sibling of koipeptidescanada.com.
Reader reviews
No reader review of this supplier is published yet. Every review is read and checked against the record before it appears. Add a review.
Open this supplier
Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.